✦ LIBER ✦

Novel CD20 monoclonal antibodies for lymphoma therapy

✍ Scribed by Shundong Cang, Nikhil Mukhi, Kemeng Wang, Delong Liu

Book ID: 119913654
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 370 KB
Volume: 5
Category: Article
ISSN: 1756-8722
DOI: 10.1186/1756-8722-5-64

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CD22-directed monoclonal antibody therap

CD22-directed monoclonal antibody therapy for lymphoma

✍ Abby B Siegel; David M Goldenberg; Alessandra Cesano; Morton Coleman; John P Leo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Monoclonal Antibody Therapy for B-Cell L

Monoclonal Antibody Therapy for B-Cell Lymphoma: Clinical Trials of an Anti-CD20 Monoclonal Antibody for B-Cell Lymphoma in Japan

✍ Kensei Tobinai 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 276 KB

CD20-negative relapse of cutaneous B-cel

CD20-negative relapse of cutaneous B-cell lymphoma after anti-CD20 monoclonal antibody therapy

✍ William Trent Massengale; Elizabeth McBurney; Jayne Gurtler 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 125 KB

148 90Y-anti-CD20 monoclonal antibody th

148 90Y-anti-CD20 monoclonal antibody therapy for recurrent B cell lymphoma

✍ Susan J. Knox; Michael L. Goris; Kirk D. Trisler; Tom A. Davis; Tina-Marie Liles 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Monoclonal antibody therapy for lymphoma

✍ Peter Campbell; Robert Marcus 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Monoclonal antibodies are an exciting advance in the treatment of lymphoma. They are safe and well-tolerated, and exhibit little cross-resistance with conventional chemotherapeutic agents. In indolent lymphomas, antibody therapy has shown useful response rates, both as first-line therapy and in rela

Anti-CD20 Antibody Therapy for B-Cell Ly

Anti-CD20 Antibody Therapy for B-Cell Lymphomas

✍ Maloney, David G. 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 673 KB